ASHP Advantage Podcasts
By ASHP Advantage
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Podcast Description
Podcast programs produced by ASHP Advantage for health care professionals.
| Name | Description | Released | Price | ||
|---|---|---|---|---|---|
|
1 |
CleanInterview with James S. Kalus Regarding Stroke Prevention in Atrial Fibrillation | Stroke Prevention in Atrial Fibrillation: Faculty Interviews (2 of 3) Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital Detroit, Michigan C.E. Credits: This activity is not eligible for continuing education credits. | 2/9/12 | Free | View In iTunes |
|
2 |
CleanInterview with Cynthia A. Sanoski Regarding Stroke Prevention in Atrial Fibrillation | Stroke Prevention in Atrial Fibrillation: Faculty Interviews (1 of 3) Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke Cynthia A. Sanoski, Pharm.D., FCCP, BCPS, Activity Chair Chair and Associate Professor Department of Pharmacy Practice Jefferson School of Pharmacy Thomas Jefferson University Philadelphia, Pennsylvania C.E. Credits: This activity is not eligible for continuing education credits. | 2/9/12 | Free | View In iTunes |
|
3 |
CleanThe Role of Pharmacist in the Management of Hyponatremia in Hospitalized Patients - Roundtable Discussion | Roundtable Discussion Regarding the Management of Hyponatremia in Hospitalized Patients (Part 3 of 3) Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Columbus, Ohio Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Michael J. Cawley, Pharm.D., RRT, CPFT Associate Professor of Clinical Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP Professor of Pharmacy Practice Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Chief Pharmacotherapy Officer Kingsbrook Jewish Medical Center Brooklyn, New York C.E. Credits: This activity is not eligible for continuing education credits. | 2/9/12 | Free | View In iTunes |
|
4 |
CleanIssues Related to Treatment Options for Hyponatremia in Hospitalized Patients - Roundtable Discussion | Roundtable Discussion Regarding the Management of Hyponatremia in Hospitalized Patients (Part 2 of 3) Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Columbus, Ohio Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Michael J. Cawley, Pharm.D., RRT, CPFT Associate Professor of Clinical Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP Professor of Pharmacy Practice Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Chief Pharmacotherapy Officer Kingsbrook Jewish Medical Center Brooklyn, New York C.E. Credits: This activity is not eligible for continuing education credits. | 2/9/12 | Free | View In iTunes |
|
5 |
CleanOverview of Hyponatremia in Hospitalized Patients - Roundtable Discussion | Roundtable Discussion Regarding the Management of Hyponatremia in Hospitalized Patients (Part 1 of 3) Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Columbus, Ohio Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Michael J. Cawley, Pharm.D., RRT, CPFT Associate Professor of Clinical Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP Professor of Pharmacy Practice Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Chief Pharmacotherapy Officer Kingsbrook Jewish Medical Center Brooklyn, New York C.E. Credits: This activity is not eligible for continuing education credits. | 2/9/12 | Free | View In iTunes |
|
6 |
CleanInterview with Susan Cornell Regarding Risks and Benefits of Emerging Type 2 Diabetes Therapies | CE in the Mornings Educational Series Faculty Interviews Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com. Susan Cornell, Pharm.D., CDE, FAPhA, FAADE Assistant Director of Experiential Education and Associate Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois C.E. Credits: This activity is not eligible for continuing education credits. | 1/29/12 | Free | View In iTunes |
|
7 |
CleanInterview with Dennis M. Williams Regarding Immunization Strategies | CE in the Mornings Educational Series Faculty Interviews Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com. Dennis M. Williams, Pharm.D., BCPS Associate Professor and Vice Chair Department of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy University of North Carolina Chapel Hill, North Carolina C.E. Credits: This activity is not eligible for continuing education credits. | 1/29/12 | Free | View In iTunes |
|
8 |
CleanInterview with Joseph Saseen Regarding Clinical Decision Making in the Management of Dyslipidemia Guidelines | CE in the Mornings Educational Series Faculty Interviews Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS Professor, Clinical Pharmacy and Family Medicine Vice Chair, Department of Clinical Pharmacy University of Colorado Anschutz Medical Center Aurora, Colorado C.E. Credits: This activity is not eligible for continuing education credits. | 1/29/12 | Free | View In iTunes |
|
9 |
CleanInterview with Craig Martin Regarding Antimicrobial Stewardship | CE in the Mornings Educational Series Faculty Interviews Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com. Craig Martin, Pharm.D., BCPS-ID Pharmacist, Specialist-Infectious Diseases Associate Professor of Pharmacy and Medicine UK HealthCare, University of Kentucky College of Pharmacy Lexington, Kentucky C.E. Credits: This activity is not eligible for continuing education credits. | 1/29/12 | Free | View In iTunes |
|
10 |
CleanInterview with Nancy L. Shapiro Regarding Stroke Prevention in Atrial Fibrillation | Stroke Prevention in Atrial Fibrillation: Faculty Interviews (3 of 3) Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke Nancy L. Shapiro, Pharm.D., FCCP, BCPS Clinical Associate Professor Operations Manager, Antithrombosis Clinic The University of Illinois at Chicago College of Pharmacy and Medical Center Chicago, Illinois C.E. Credits: This activity is not eligible for continuing education credits. | 1/29/12 | Free | View In iTunes |
|
11 |
CleanOptimizing Bone Health in Cancer Patients | Optimizing Bone Health in Cancer Patients Summary: Improvements in cancer treatment have increased survival and the need for effective interventions to reduce the risk for skeletal-related events including pathologic bone fractures, spinal cord compression, need for surgery or radiation therapy to bone, and hypercalcemia of malignancy. Many cancer therapies cause bone loss, which increases the risk for fractures. Bisphosphonates are useful for treating bone metastases and slowing or preventing cancer treatment-induced bone loss (CTIBL). These drugs also may reduce the risk of recurrence and improve survival in patients with early breast cancer or other solid tumors. RANK-ligand Inhibitors have also been shown to decrease skeletal-related events in patients with bone metastases from solid tumors. Other agents for the treatment of bone metastases are under investigation. Knowledge of the role of bisphosphonates and new and emerging bone-targeted therapies in treating patients with bone metastases or CTIBL will enable pharmacists to take an active role in the management of these patients. Chad M. Barnett, Pharm.D., BCOP Co-Chair Clinical Pharmacy Specialist Breast Oncology Division of Pharmacy University of Texas M.D. Anderson Cancer Center Houston, Texas C.E. Credits: This activity was recorded on April 14, 2011. Continuing education credit for this podcast is available through May 23, 2012. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Advantage CE Testing Center. | 5/19/11 | Free | View In iTunes |
|
12 |
CleanPotential Use of Platelet Function and Genetic Testing in Guiding Oral Antiplatelet Therapy in Acute Coronary Syndrome | Potential Use of Platelet Function and Genetic Testing in Guiding Oral Antiplatelet Therapy in Acute Coronary Syndrome Summary: The content for this podcast was adapted from an interview with Julie Oestreich recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Oestreich is Assistant Professor in the Department of Pharmacy Practice in the College of Pharmacy at the University of Nebraska Medical Center (UNMC) in Omaha. Dr. Oestreich discusses some of the clinical challenges in oral antiplatelet therapy, especially as they relate to platelet function and genetic testing. Julie H. Oestreich, Pharm.D., Ph.D. Assistant Professor of Pharmacy Practice College of Pharmacy University of Nebraska Medical Center Omaha, Nebraska C.E. Credits: Not available for this activity. | 2/4/11 | Free | View In iTunes |
|
13 |
CleanCurrent Options for Managing Antiplatelet Therapy in Patients with Acute Coronary Syndrome. | Current Options for Managing Antiplatelet Therapy in Patients with Acute Coronary Syndrome. Summary: The content for this podcast was adapted from an interview with Toby Trujillo recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Trujillo is Associate Professor of Clinical Pharmacy at the University of Colorado Denver School of Pharmacy in Aurora, Colorado. He also serves as Clinical Specialist in cardiovascular pharmacotherapy and anticoagulation at University of Colorado Hospital. Dr. Trujillo discusses issues related to current options for managing antiplatelet therapy in patients with acute coronary syndrome. Toby C. Trujillo, Pharm.D., BCPS (AQ Cardiology) Associate Professor University of Colorado Denver School of Pharmacy Clinical Specialist – Cardiology/Anticoagulation University of Colorado Hospital Aurora, Colorado C.E. Credits: Not available for this activity. | 2/4/11 | Free | View In iTunes |
|
14 |
CleanAlternative Approaches to Oral Antiplatelet Management in Acute Coronary Syndrome | Alternative Approaches to Oral Antiplatelet Management in Acute Coronary Syndrome Summary: The content for this podcast was adapted from an interview with Paul Dobesh recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Dobesh is Associate Professor of Pharmacy Practice at the University of Nebraska Medical Center in Omaha. He also is chair of this educational initiative coordinated by ASHP Advantage. Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology) Associate Professor of Pharmacy Practice College of Pharmacy University of Nebraska Medical Center Omaha, Nebraska C.E. Credits: Not available for this activity. | 2/4/11 | Free | View In iTunes |
|
15 |
CleanRole of the Pharmacist in Identifying and Overcoming Barriers to Appropriate and Well-managed Antithrombotic Therapy | Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with Ann Wittkowsky that was recorded on December 5th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Wittkowsky is Clinical Professor at the University of Washington School of Pharmacy, and Director of Anticoagulation Services at the University of Washington Medical Center in Seattle, Washington. Dr. Wittkowsky will discuss the Role of the Pharmacist in Identifying and Overcoming Barriers to Appropriate and Well-managed Antithrombotic Therapy. Ann K. Wittkowsky, Pharm.D., CACP, FASHP, FCCP Clinical Professor University of Washington School of Pharmacy Director, Anticoagulation Services University of Washington Medical Center Seattle, Washington C.E. Credits: Not available for this activity. | 1/31/11 | Free | View In iTunes |
|
16 |
CleanFuture Directions: Emerging Therapies for Stroke Prevention in Atrial Fibrillation | Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with James Kalus that was recorded on December 6th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Kalus is Senior Manager, Patient Care Services of the Department of Pharmacy Services at Henry Ford Hospital in Detroit, Michigan. Dr. Kalus will discuss Future Directions: Emerging Therapies for Stroke Prevention in Atrial Fibrillation. James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital Detroit, Michigan C.E. Credits: Not available for this activity. | 1/31/11 | Free | View In iTunes |
|
17 |
CleanStroke Prevention in Atrial Fibrillation: Reviewing the Basics. | Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with Cynthia Sanoski that was recorded on December 5th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Sanoski is Chair and Associate Professor of the Department of Pharmacy Practice at Jefferson School of Pharmacy, Thomas Jefferson University in Philadelphia, Pennsylvania. Dr. Sanoski will discuss Stroke Prevention in Atrial Fibrillation: Reviewing the Basics. Cynthia A. Sanoski, Pharm.D., FCCP, BCPS, Initiative Chair Chair and Associate Professor Department of Pharmacy Practice Jefferson School of Pharmacy Thomas Jefferson University Philadelphia, Pennsylvania C.E. Credits: Not available for this activity. | 1/31/11 | Free | View In iTunes |
|
18 |
CleanPractical Applications and Opportunities Presented by REMS | Clinical Considerations of Risk Evaluation and Mitigation Strategies in Health Care Systems: Design, Implementation, and Management Summary: The content for this podcast was adapted from an interview with JoAnn Stubbings recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Ms. Stubbings is Manager of Research and Public Policy in the Ambulatory Care Pharmacy Department at the University of Illinois (UIC) at Chicago College of Pharmacy and Clinical Associate Professor in the Department of Pharmacy Practice. She also serves as chair of the risk evaluation and mitigation strategies educational initiative coordinated by ASHP Advantage. Ms. Stubbings will discuss practical applications and opportunities presented by REMS. JoAnn Stubbings, MHCA, B.S. Pharm. Clinical Associate Professor Manager, Research and Public Policy University of Illinois at Chicago College of Pharmacy Chicago, Illinois C.E. Credits: Not available for this activity. | 1/31/11 | Free | View In iTunes |
|
19 |
CleanThe Background, History and Current Status of Risk Evaluation and Mitigation Strategies. | The Background, History and Current Status of Risk Evaluation and Mitigation Strategies. Summary: The content for this podcast was adapted from an interview with Stephen Goldman recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Goldman is an independent consultant with extensive experience in academic and clinical medicine, public health, federal medical product safety regulations, and the pharmaceutical industry. Stephen A. Goldman, M.D., FAPM, DFAPA Former Medical Director, MedWatch,U.S. Food and Drug Administration Managing Member, Stephen A. Goldman Consulting Services, LLC Morris Plains, New Jersey C.E. Credits: Not available for this activity. | 1/31/11 | Free | View In iTunes |
|
20 |
CleanA Look at the Future of Biosimilars and What Physicians and Pharmacists Should Anticipate with Their Arrival on the U.S. Market | Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 1: Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 2: Development of a VTE Risk Assessment Model and Protocol Jordan C. Messler, M.D., FHM Overview Venous thromboembolism (deep vein thrombosis, pulmonary embolism, or both) remains a significant threat to patient safety. At least 100,000 deaths are attributable to venous thromboembolism (VTE) each year in the United States. VTE is primarily a problem of hospitalized and recently-hospitalized patients. Although the majority of medical and surgical inpatients have multiple risk factors for VTE, evidence shows that only 30% to 50% of patients receive adequate prophylaxis. Barriers to the use of prophylaxis include lack of familiarity with published clinical guidelines, underestimation of VTE risk, concern over risk of bleeding from anticoagulants, and difficulty achieving hospital-wide implementation of risk assessment procedures. To improve inpatient safety, regulatory and professional organizations have endorsed practice guidelines for VTE prophylaxis. Current guidelines from the American College of Chest Physicians recommend that hospitals develop a formal strategy to prevent thromboembolic complications and, more specifically, provide prophylaxis in patients with VTE risk factors. This activity will outline a multidisciplinary team approach to the implementation of effective VTE risk assessment and prevention strategies in hospitalized patients. Physician leadership of the multidisciplinary team is essential to integrate VTE risk assessment processes into routine patient care practices. A case study will be used to illustrate important concepts as well as provide active learning for participants. Continuing Education This activity was recorded on May 4, 2010. Continuing education credit for this podcast is available through November 30, 2011, for pharmacists, physicians, nurses, nurse practitioners, and case managers. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Advantage CE Testing Center. Complete information and continuing education accreditation statements are included in the audio podcast and are also found in the presentation handout (PDF), which is included with the podcast. This activity is planned and coordinated by ASHP Advantage and is supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC. | 9/15/10 | Free | View In iTunes |
|
21 |
CleanA Look at the Future of Biosimilars and What Physicians and Pharmacists Should Anticipate with Their Arrival on the U.S. Market | Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 1: Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 2: Development of a VTE Risk Assessment Model and Protocol Jordan C. Messler, M.D., FHM Overview Venous thromboembolism (deep vein thrombosis, pulmonary embolism, or both) remains a significant threat to patient safety. At least 100,000 deaths are attributable to venous thromboembolism (VTE) each year in the United States. VTE is primarily a problem of hospitalized and recently-hospitalized patients. Although the majority of medical and surgical inpatients have multiple risk factors for VTE, evidence shows that only 30% to 50% of patients receive adequate prophylaxis. Barriers to the use of prophylaxis include lack of familiarity with published clinical guidelines, underestimation of VTE risk, concern over risk of bleeding from anticoagulants, and difficulty achieving hospital-wide implementation of risk assessment procedures. To improve inpatient safety, regulatory and professional organizations have endorsed practice guidelines for VTE prophylaxis. Current guidelines from the American College of Chest Physicians recommend that hospitals develop a formal strategy to prevent thromboembolic complications and, more specifically, provide prophylaxis in patients with VTE risk factors. This activity will outline a multidisciplinary team approach to the implementation of effective VTE risk assessment and prevention strategies in hospitalized patients. Physician leadership of the multidisciplinary team is essential to integrate VTE risk assessment processes into routine patient care practices. A case study will be used to illustrate important concepts as well as provide active learning for participants. Continuing Education This activity was recorded on May 4, 2010. Continuing education credit for this podcast is available through November 30, 2011, for pharmacists, physicians, nurses, nurse practitioners, and case managers. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Advantage CE Testing Center. Complete information and continuing education accreditation statements are included in the audio podcast and are also found in the presentation handout (PDF), which is included with the podcast. This activity is planned and coordinated by ASHP Advantage and is supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC. | 9/15/10 | Free | View In iTunes |
| 22 | CleanPharmacy Technician Roles in Sterile IV Compounding: Challenges, Opportunities, and Competencies (Handout) | The handout for these three presentations includes the slides, speaker biographies, and additional information. Part 1: Innovative Pharmacy Technician Roles in Action Rowell Daniels, Pharm.D., M.S. Part 2: Case Study: A Tech-Check-Tech Pilot Study in an Academic Medical Center Beth S. Williams, Pharm.D., BCPS Part 3: Trained, Tested, and Trusted: PTCB Update Miriam A. Mobley Smith, B.S.Pharm., Pharm.D. Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths. Continuing Education The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T. Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit Expected Duration: 2 hours Post Test: Visit www.ashpadvantage.com/podcasts This activity is planned and coordinated by ASHP Advantage. It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB). | 3/2/10 | Free | View In iTunes |
|
23 |
CleanPharmacy Technician Roles in Sterile IV Compounding: Challenges, Opportunities, and Competencies (Part 3 of 3) | Trained, Tested, and Trusted: PTCB Update Miriam A. Mobley Smith, B.S.Pharm., Pharm.D. Part 1: Innovative Pharmacy Technician Roles in Action Rowell Daniels, Pharm.D., M.S. Part 2: Case Study: A Tech-Check-Tech Pilot Study in an Academic Medical Center Beth S. Williams, Pharm.D., BCPS Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths. Continuing Education The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T. Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit Expected Duration: 2 hours Post Test: Visit www.ashpadvantage.com/podcasts This activity is planned and coordinated by ASHP Advantage. It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB). | 3/2/10 | Free | View In iTunes |
|
24 |
CleanPharmacy Technician Roles in Sterile IV Compounding: Challenges, Opportunities, and Competencies (Part 2 of 3) | Case Study: A Tech-Check-Tech Pilot Study in an Academic Medical Center Beth S. Williams, Pharm.D., BCPS Part 1: Innovative Pharmacy Technician Roles in Action Rowell Daniels, Pharm.D., M.S. Part 3: Trained, Tested, and Trusted: PTCB Update Miriam A. Mobley Smith, B.S.Pharm., Pharm.D. Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths. Continuing Education The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T. Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit Expected Duration: 2 hours Post Test: Visit www.ashpadvantage.com/podcasts This activity is planned and coordinated by ASHP Advantage. It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB). | 3/2/10 | Free | View In iTunes |
|
25 |
CleanPharmacy Technician Roles in Sterile IV Compounding: Challenges, Opportunities, and Competencies (Part 1 of 3) | Innovative Pharmacy Technician Roles in Action Rowell Daniels, Pharm.D., M.S. Part 2: Case Study: A Tech-Check-Tech Pilot Study in an Academic Medical Center Beth S. Williams, Pharm.D., BCPS (30 minutes) Part 3: Trained, Tested, and Trusted: PTCB Update Miriam A. Mobley Smith, B.S.Pharm., Pharm.D. Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths. Continuing Education The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T. Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit Expected Duration: 2 hours See www.ashpadvantage.com/podcasts to take the post-test. This activity is planned and coordinated by ASHP Advantage. It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB). | 3/2/10 | Free | View In iTunes |
|
26 |
CleanMedication Safety Radio Interview with Scott T. Micek - WIBW Topeka, Kansas | During the week of March 2nd through the 8th in 2008, ASHP and the ASHP Research and Education Foundation marked National Patient Safety Awareness Week with a radio tour. The radio tour emphasized the pharmacists' role in medication safety. Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems. This podcast includes the interview with WIBW in Topeka, Kansas. Permission to share this interview with the public was granted by the Kansas Information Network and James Doblin, who conducted the interview.) The Barnes-Jewish Hospital's team, which was led by Dr. Micek, received the 2007 Award for Excellence in Medication-Use Safety. The ASHP Foundation created the Award for Excellence in Medication-Use Safety in 2004. It is the only award program to honor a pharmacist-led, multidisciplinary team for its significant institution-wide system improvements relating to medication use. The $50,000 award recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award is sponsored by the Cardinal Health Foundation.For more information, please visit www.ashpfoundation.org. | 9/11/08 | Free | View In iTunes |
|
27 |
CleanMedication Safety Radio Interview with Scott T. Micek - Metro Networks Minneapolis | During the week of March 2nd through the 8th in 2008, ASHP and the ASHP Research and Education Foundation marked National Patient Safety Awareness Week with a radio tour. The radio tour emphasized the pharmacists' role in medication safety. Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems. This podcast includes the interview with WIBW in Topeka, Kansas. Permission to share this interview with the public was granted by the Kansas Information Network and James Doblin, who conducted the interview.) The Barnes-Jewish Hospital's team, which was led by Dr. Micek, received the 2007 Award for Excellence in Medication-Use Safety. The ASHP Foundation created the Award for Excellence in Medication-Use Safety in 2004. It is the only award program to honor a pharmacist-led, multidisciplinary team for its significant institution-wide system improvements relating to medication use. The $50,000 award recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award is sponsored by the Cardinal Health Foundation.For more information, please visit www.ashpfoundation.org. | 9/11/08 | Free | View In iTunes |
| Total: 27 Episodes |
Customer Reviews
Pharmacy Technician episode doesn
The Pharmacy Technician episode doesn' work. No sound. Doesn't play.
VERY INFORMATIVE
GIVES YOU UP-TO-DATE INFORMATION ON PHARMACY PRACTICE
Listeners also subscribed to
- Art of Pharmacy: UGA College of Pharmacy
- Brinkley Warren
- View In iTunes
- News for UCSF School of Pharmacy PharmD students
- UCSF School of Pharmacy
- View In iTunes
- Free
- Category: Higher Education
- Language: English
- © Copyright 2011. American Society of Health-System Pharmacists
